The White House Office of National Drug Control Policy, Truth Initiative and Ad Council yesterday unveiled a public education campaign focused on preventing and reducing misuse of opioids among youth and young adults.
News
Latest
Suicide rates rose in every state but Nevada between 1999 and 2016, climbing 30% or more in 25 states, according to the latest Vital Signs report by the Centers for Disease Control and Prevention.
Today, we are proud to sponsor our second annual #HAVhope Day of Awareness.
More than 45 organizations, including the AHA, today encouraged members of the Senate Judiciary Committee to support the Creating and Restoring Equal Access to Equivalent Samples Act.
The Centers for Medicare & Medicaid Services today finalized without changes its “extreme and uncontrollable circumstances” policy for hospitals participating in the Comprehensive Care for Joint Replacement Payment Model.
The Centers for Disease Control and Prevention today issued updated recommendations for managing and reporting Shigella infections that were treated with ciprofloxacin or azithromycin.
Federal Communications Commission Chairman Ajit Pai today, as urged by the AHA, asked his colleagues to approve quickly an order that would increase funding for the Rural Health Care Program by $171 million.
America’s hospitals supported 16.5 million jobs and almost $3 trillion in economic activity in 2016, according to the AHA’s latest annual report on hospitals as economic drivers in their communities.
The House Ways and Means Committee today held a hearing examining whether consumer-directed health plans, which pair a health savings account with a high-deductible health plan, hold potential to lower costs and expand access to health care.
The House Energy and Commerce Health Subcommittee today held a hearing on draft legislation that would reauthorize the Pandemic and All-Hazards Preparedness Act through 2023.
The Department of Health and Human Services seeks public comment on a planned initiative to develop a workgroup “to facilitate constructive, high-level dialogue between HHS leadership and those focused on innovating and investing in the health care industry.”
President Trump today signed into law AHA-supported bipartisan legislation (S. 2372) to streamline and consolidate the Department of Veterans Affairs' community care programs into a permanent Veterans Community Care Program.
Hospital-acquired conditions declined by 8% between 2014 and 2016, preventing an estimated 8,000 deaths and $2.9 billion in health care costs, according to results reported today by the Agency for Healthcare Research and Quality.
The Medicare Hospital Insurance Trust Fund will have sufficient funds to cover its obligations until 2026, three years earlier than projected last year, according to the latest annual report from the Medicare Board of Trustees.
Hospira is voluntarily recalling two lots of naloxone hydrochloride injection, used to treat opioid overdoses, because they may contain particulate matter on the syringe plunger, the Food and Drug Administration announced yesterday.
A Maine court yesterday ordered the state health commissioner to submit to the Centers for Medicare & Medicaid Services by June 11 a state plan amendment ensuring Medicaid eligibility for qualified low-income residents as approved by voters in a state referendum last November.
The Centers for Medicare & Medicaid Services yesterday released the first Medicaid and Children’s Health Insurance Program Scorecard, intended to drive improvement in state and federal alignment, beneficiary health outcomes and program administration.
Hospitals participating in the Bundled Payments for Care Improvement initiative and Comprehensive Care for Joint Replacement model vary with respect to a number of organizational characteristics.
Total reimbursement for brand-name prescription drugs in Medicare Part D increased 77% between 2011 and 2015, nearly six times faster than inflation, despite a 17% decrease in the number of prescriptions.
Medtronic has recalled more than 204,000 devices used to assist hospital and other patients with end-stage heart failure due to the potential for power source interruptions, the Food and Drug Administration reported Friday.